Anders Boyd

6.4k total citations
229 papers, 3.8k citations indexed

About

Anders Boyd is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Anders Boyd has authored 229 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Epidemiology, 102 papers in Infectious Diseases and 88 papers in Hepatology. Recurrent topics in Anders Boyd's work include Hepatitis C virus research (86 papers), Hepatitis B Virus Studies (78 papers) and HIV/AIDS Research and Interventions (74 papers). Anders Boyd is often cited by papers focused on Hepatitis C virus research (86 papers), Hepatitis B Virus Studies (78 papers) and HIV/AIDS Research and Interventions (74 papers). Anders Boyd collaborates with scholars based in Netherlands, France and United States. Anders Boyd's co-authors include Karine Lacombe, Pierre‐Marie Girard, Fabien Zoulim, Steven Collins, Maria Prins, Udi Davidovich, Viviane Kovess–Masféty, Guillaume Arlet, Joël Gozlan and A Fletcher and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Anders Boyd

210 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Boyd Netherlands	33	1.7k	1.0k	1.0k	587	362	229	3.8k
Nancy F. Crum‐Cianflone United States	45	2.2k 1.3×	598 0.6×	2.3k 2.3×	391 0.7×	388 1.1×	153	5.7k
David C. Perlman United States	32	2.4k 1.4×	557 0.5×	1.8k 1.8×	154 0.3×	139 0.4×	171	3.7k
Annalisa Saracino Italy	29	981 0.6×	285 0.3×	1.5k 1.5×	186 0.3×	129 0.4×	212	3.2k
Mark R. Wallace United States	38	2.2k 1.3×	350 0.3×	2.2k 2.2×	314 0.5×	62 0.2×	131	5.3k
Jennifer Hoy Australia	47	2.9k 1.7×	357 0.3×	5.3k 5.2×	562 1.0×	176 0.5×	242	8.3k
Amy Weintrob United States	34	1.6k 0.9×	447 0.4×	1.6k 1.6×	288 0.5×	35 0.1×	98	4.0k
Joseph Doyle Australia	32	2.4k 1.4×	1.8k 1.7×	965 1.0×	73 0.1×	120 0.3×	177	4.0k
Nina Singh United States	37	3.6k 2.1×	593 0.6×	4.9k 4.8×	102 0.2×	126 0.3×	76	7.3k
Eric Chamot United States	30	964 0.6×	170 0.2×	764 0.8×	84 0.1×	173 0.5×	76	3.0k
Robert S. Holzman United States	41	2.3k 1.3×	183 0.2×	2.3k 2.3×	411 0.7×	49 0.1×	156	6.3k

Countries citing papers authored by Anders Boyd

Since Specialization

Citations

This map shows the geographic impact of Anders Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Boyd more than expected).

Fields of papers citing papers by Anders Boyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Boyd. The network helps show where Anders Boyd may publish in the future.

Co-authorship network of co-authors of Anders Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Boyd. A scholar is included among the top collaborators of Anders Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Boyd. Anders Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoornenborg, Elske, Maarten F. Schim van der Loeff, Anders Boyd, et al.. (2025). Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024. Eurosurveillance. 30(26). 1 indexed citations

Boyd, Anders, et al.. (2024). Hepatitis C virus infection is uncommon at baseline and during follow-up among individuals using PrEP in the Dutch national PrEP programme between 2019 and 2022. Sexually Transmitted Infections. 100(5). 288–294. 3 indexed citations

Boyd, Anders, Vita W. Jongen, Liza Coyer, et al.. (2024). Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort. PLoS Medicine. 21(5). e1004328–e1004328. 5 indexed citations

Mohareb, Amir M., Arthur Y. Kim, Joseph Larmarange, et al.. (2024). What does the scale‐up of long‐acting HIV pre‐exposure prophylaxis mean for the global hepatitis B epidemic?. Journal of the International AIDS Society. 27(3). e26218–e26218. 3 indexed citations

Mohareb, Amir M., Arthur Y. Kim, Anders Boyd, et al.. (2024). Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model. BMJ Open. 14(1). e073498–e073498.

Béguelin, Charles, Andrew Atkinson, Anders Boyd, et al.. (2023). Hepatitis delta infection among persons living with HIV in Europe. Liver International. 43(4). 819–828. 13 indexed citations

Boyd, Anders, Sylvia M. Brakenhoff, Rosan A van Zoest, et al.. (2023). Socio‐economic factors associated with loss to follow‐up among individuals with HCV: A Dutch nationwide cross‐sectional study. Liver International. 44(1). 52–60. 2 indexed citations

Wynberg, Elke, Hugo D.G. van Willigen, Pythia T. Nieuwkerk, et al.. (2023). Two‐year trajectories of COVID‐19 symptoms and their association with illness perception: A prospective cohort study in Amsterdam, the Netherlands. Influenza and Other Respiratory Viruses. 17(10). e13190–e13190. 6 indexed citations

Santen, Daniela K van, Sara Lodi, Paul Dietze, et al.. (2023). Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials. Addiction. 118(6). 1116–1126. 7 indexed citations

10.

Santen, Daniela K van, Marcel Buster, Anders Boyd, et al.. (2023). Low prevalence of current and past SARS-CoV-2 infections among visitors and staff members of homelessness services in Amsterdam at the end of the second wave of infections in the Netherlands. PLoS ONE. 18(7). e0288610–e0288610. 1 indexed citations

11.

Mohareb, Amir M., Arthur Y. Kim, Patrick Coffié, et al.. (2022). Clearance of Hepatitis B e Antigen in Untreated Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-analysis. The Journal of Infectious Diseases. 226(10). 1761–1770. 4 indexed citations

12.

Foerster, Sunniva, et al.. (2022). Pharmacodynamics of Ceftriaxone, Ertapenem, Fosfomycin and Gentamicin in Neisseria gonorrhoeae. Antibiotics. 11(3). 299–299. 4 indexed citations

13.

Miailhes, Patrick, Caroline Lascoux‐Combe, Sarah Maylin, et al.. (2021). Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study. Journal of Antimicrobial Chemotherapy. 76(11). 3009–3019. 4 indexed citations

14.

Miailhes, Patrick, Caroline Lascoux‐Combe, Sarah Maylin, et al.. (2021). Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus–Hepatitis B Virus–Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort. Clinical Infectious Diseases. 74(6). 1012–1021. 4 indexed citations

15.

Santen, Daniela K van, Anders Boyd, Amy Matser, et al.. (2021). The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial. Addiction. 116(11). 3115–3126. 18 indexed citations

16.

Rooijen, Martijn S. van, et al.. (2020). Enhancing help-seeking behaviour among men who have sex with men at risk for sexually transmitted infections: the syn.bas.in randomised controlled trial. Sexually Transmitted Infections. 97(1). 11–17. 13 indexed citations

17.

Lambert-Niclot, Sidonie, Anders Boyd, Djeneba Fofana, et al.. (2019). INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels. Open Forum Infectious Diseases. 6(5). ofz177–ofz177. 7 indexed citations

18.

Surgers, Laure, Peter Boersma, PM Girard, et al.. (2018). Molecular epidemiology of ESBL-producing E. coli and K. pneumoniae: establishing virulence clusters. SHILAP Revista de lepidopterología. 3 indexed citations

19.

Marra, Elske, et al.. (2018). Incidence and Clearance of Anal High-risk Human Papillomavirus Infections and Their Determinants Over 5 Years Among Human Immunodeficiency Virus–negative Men Who Have Sex With Men. Clinical Infectious Diseases. 68(9). 1556–1565. 17 indexed citations

20.

Velde, Sarah Van de, Anders Boyd, & Viviane Kovess–Masféty. (2012). Mental health in Europe: a gender perspective. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact